Vidadala, R. S. R., Rivas, K. L., Ojo, K. K., Hulverson, M. A., Zambriski, J. A., Bruzual, I., . . . Maly, D. J. (2016). Development of an Orally Available and Central Nervous System (CNS)-Penetrant Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-à-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis. J Med Chem.
Stile di citazione ChicagoVidadala, Rama Subba Rao, et al. "Development of an Orally Available and Central Nervous System (CNS)-Penetrant Toxoplasma Gondii Calcium-dependent Protein Kinase 1 (TgCDPK1) Inhibitor With Minimal Human Ether-à-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis." J Med Chem 2016.
Citazione MLAVidadala, Rama Subba Rao, et al. "Development of an Orally Available and Central Nervous System (CNS)-Penetrant Toxoplasma Gondii Calcium-dependent Protein Kinase 1 (TgCDPK1) Inhibitor With Minimal Human Ether-à-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis." J Med Chem 2016.